Back to news
finance

Artivion Shares Fall Sharply After Convertible Senior Notes Offering Announcement

Artivion, a medical device company, experienced a significant drop in its stock value today. This downturn follows the announcement of a proposed private offering of convertible senior notes.

5/13/2026, 1:01:58 AM

Shares of Artivion, Inc. (NYSE: AORT) saw a considerable decline in trading today, November 13, 2023. The significant market reaction appears to be linked to the company's recent disclosure regarding a private offering of convertible senior notes. According to Investing.com, the medical technology firm, which specializes in products for treating aortic and peripheral vascular diseases, revealed its intentions to offer $175 million in senior unsecured notes due in 2028. These notes are designed to be convertible into cash, shares of Artivion's common stock, or a combination of both, at the company's discretion. The initial purchasers for this proposed offering will also have an option to acquire up to an additional $26.25 million in notes within a 13-day period from the date of the issuance. The specific interest rate, conversion rate, and other terms of these notes have not yet been finalized and will be determined during the pricing of the offering. Artivion intends to use the net proceeds from this offering for several purposes. A portion of the funds will be allocated to repurchasing a portion of its existing 2.25% convertible senior notes due in 2025. This repurchase will involve either cash, shares of common stock, or a combination thereof. Any notes acquired in this manner will subsequently be cancelled. The remainder of the net proceeds is earmarked for general corporate purposes. This could include funding working capital, capital expenditures, potential acquisitions, and other strategic initiatives. The offering is being directed toward qualified institutional buyers, executed as a private placement pursuant to Rule 144A under the Securities Act of 1933, as amended. It is important to note that neither the notes nor any common stock that may be issued upon conversion have been registered under the Securities Act or any state securities laws. Consequently, they cannot be offered or sold in the United States without registration or an applicable exemption from registration requirements.

Share